Sivik Global Healthcare LLC In its 13F for Q2 2025 (holdings as of June 30, 2025, filed July 25, 2025), Sivik Global Healthcare LLC reported 38 stock positions worth $223.6 million . Its top holding was SS SPDR S&P Biotech ETF (XBI) at 9.3% of the portfolio, followed by Tenet Healthcare (THC, 6.7% ) and HCA Healthcare (HCA, 4.3% ). Compared with Q1 2025, it opened 10 new positions, sold out of 1, added to 17 and reduced 7. The biggest buy was a new position in Quest Diagnostics (DGX) and the biggest sale an exit from Astrazeneca PLC-Spons ADR (AZN).
Location GREENWICH, CT
CIK 0001596452
Portfolio Value $223.6M (Q2 2025) Holdings 38 stocks · $223.6M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q1 2025 XBI SS SPDR S&P Biotech ETF 250,000 $20.7M No change THC Tenet Healthcare Corp. 85,000 $15.0M Add +21.4% HCA HCA Healthcare Inc. 25,000 $9.6M No change MCK McKesson Corp. 13,000 $9.5M Add +18.2% UHS Universal Health Services-B 52,500 $9.5M Add +61.5% BSX Boston Scientific Corp. 80,000 $8.6M Reduce -20.0% LLY Eli Lilly & Co. 11,000 $8.6M Add +22.2% DHR Danaher Corp. 40,000 $7.9M Add +14.3% CAH Cardinal Health Inc. 45,000 $7.6M Reduce -10.0% SYK Stryker Corp. 19,000 $7.5M Add +8.6% COR Cencora Inc. 25,000 $7.5M No change ISRG Intuitive Surgical Inc. 13,000 $7.1M Reduce -7.1% MDT Medtronic PLC 80,000 $7.0M Add +6.7% NVO Novo-Nordisk A/S-Spons ADR 100,000 $6.9M Add +42.9% HUM Humana Inc. 27,000 $6.6M Add +17.4% WAT Waters Corp. 18,000 $6.3M Add +5.9% GILD Gilead Sciences Inc. 50,000 $5.5M Add +25.0% CI The Cigna Group 16,500 $5.5M Add +32.0% ABT Abbott Laboratories 39,200 $5.3M Reduce -12.9% A Agilent Technologies Inc. 45,000 $5.3M Reduce -10.0% UNH Unitedhealth Group Inc. 15,000 $4.7M Add +200.0% SEM Select Medical Holdings Corp. 300,000 $4.6M Add +50.0% DGX Quest Diagnostics Inc. 25,000 $4.5M New RVTY Revvity Inc. 45,000 $4.4M New BIO Bio-Rad Laboratories-A 18,000 $4.3M New SNN Smith & Nephew PLC -Spon ADR 140,000 $4.3M Add +16.7% RGEN Repligen Corp. 30,000 $3.7M New WST West Pharmaceutical Services 15,000 $3.3M Add +20.0% EHC Encompass Health Corp. 25,000 $3.1M Reduce -51.5% AVTR Avantor Inc. 225,000 $3.0M Add +12.5% ALGN Align Technology Inc. 15,000 $2.8M New SGRY Surgery Partners Inc. 125,000 $2.8M No change BAX Baxter International Inc. 75,000 $2.3M Reduce -57.1% COO The Cooper Cos Inc. 30,000 $2.1M New ALNY Alnylam Pharmaceuticals Inc. 6,500 $2.1M New MDGL Madrigal Pharmaceuticals Inc. 5,000 $1.5M New ARGX Argenx SE - ADR 2,500 $1.4M New INSP Inspire Medical Systems Inc. 10,000 $1.3M New
Options reported separately and not counted above: PUT - SPY 100 @ 599 EXP 07/18/2025 puts ($24.0M), PUT - SPY 100 @ 596 EXP 07/18/2025 puts ($23.8M), PUT - SPY 100 @ 602 EXP 07/31/2025 puts ($18.1M), PUT - SPY 100 @ 597 EXP 07/18/2025 puts ($17.9M), PUT - SPY 100 @ 610 EXP 08/15/2025 puts ($15.3M), PUT - SPY 100 @ 607 EXP 07/31/2025 puts ($15.2M), PUT - SPY 100 @ 600 EXP 08/15/2025 puts ($15.0M), PUT - SPY 100 @ 593 EXP 07/31/2025 puts ($14.8M).
Portfolio Sells Q1 2025 → Q2 2025 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2025 % Of Portfolio Change To Portfolio ▲ AZN Astrazeneca PLC-Spons ADR Sold out 0.00% −2.81 BAX Baxter International Inc. Reduce -57.1% 1.02% −2.26 BSX Boston Scientific Corp. Reduce -20.0% 3.84% −1.67 EHC Encompass Health Corp. Reduce -51.5% 1.37% −1.49 ABT Abbott Laboratories Reduce -12.9% 2.38% −0.88 A Agilent Technologies Inc. Reduce -10.0% 2.38% −0.82 ISRG Intuitive Surgical Inc. Reduce -7.1% 3.16% −0.63 CAH Cardinal Health Inc. Reduce -10.0% 3.38% −0.38
Portfolio Buys Q1 2025 → Q2 2025 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2025 % Of Portfolio Change To Portfolio ▼ DGX Quest Diagnostics Inc. New 2.01% +2.01 RVTY Revvity Inc. New 1.95% +1.95 BIO Bio-Rad Laboratories-A New 1.94% +1.94 RGEN Repligen Corp. New 1.67% +1.67 THC Tenet Healthcare Corp. Add +21.4% 6.69% +1.54 ALGN Align Technology Inc. New 1.27% +1.27 COO The Cooper Cos Inc. New 0.95% +0.95 ALNY Alnylam Pharmaceuticals Inc. New 0.95% +0.95 UHS Universal Health Services-B Add +61.5% 4.25% +0.92 MDGL Madrigal Pharmaceuticals Inc. New 0.68% +0.68 UNH Unitedhealth Group Inc. Add +200.0% 2.09% +0.66 ARGX Argenx SE - ADR New 0.62% +0.62 INSP Inspire Medical Systems Inc. New 0.58% +0.58 NVO Novo-Nordisk A/S-Spons ADR Add +42.9% 3.09% +0.43 MCK McKesson Corp. Add +18.2% 4.26% +0.21 SEM Select Medical Holdings Corp. Add +50.0% 2.04% +0.21 CI The Cigna Group Add +32.0% 2.44% +0.19 SNN Smith & Nephew PLC -Spon ADR Add +16.7% 1.92% +0.06 GILD Gilead Sciences Inc. Add +25.0% 2.48% +0.03 WST West Pharmaceutical Services Add +20.0% 1.47% −0.06 SYK Stryker Corp. Add +8.6% 3.36% −0.20 LLY Eli Lilly & Co. Add +22.2% 3.84% −0.23 HUM Humana Inc. Add +17.4% 2.95% −0.37 DHR Danaher Corp. Add +14.3% 3.53% −0.39 AVTR Avantor Inc. Add +12.5% 1.35% −0.42 MDT Medtronic PLC Add +6.7% 3.12% −0.57 WAT Waters Corp. Add +5.9% 2.81% −0.62
Options Activity Q1 2025 → Q2 2025 Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 34 $131.7M XBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK Q1 2026 34 $131.7M XBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK Q4 2025 41 $204.8M XBI, LLY, THC, MCK, HCA Q3 2025 35 $190.5M XBI, LLY, HCA, THC, DHR Q2 2025 38 $223.6M XBI, THC, HCA, MCK, UHS Q1 2025 29 $182.9M XBI, BSX, THC, HCA, LLY Q4 2024 36 $180.8M XBI, LLY, BSX, MCK, SYK Q3 2024 33 $234.6M XBI, LLY, THC, NVO, UHS Q2 2024 37 $223.9M LLY, NVO, MCK, THC, BSX Q1 2024 46 $275.1M XBI, LLY, NVO, BSX, TMO